Skip to content
Monday 10 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,867.76
-0.31%
DAX
26,406.17
+0.33%
CAC 40
8,703.97
-0.13%
STOXX 50
6,540.21
+0.25%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Astrazeneca

  • Kent Covid variant ‘no more deadly’ than original coronavirus strain

    March 31, 2021

    The Kent Covid variant, which is now the UK’s dominant version of coronavirus, is no more deadly than the original strain, research by Public Health England (PHE) has found.  A PHE study matched 2,800 cases of the B117 variant first identified in Kent against the original Covid strain and found there was no significant difference in [...]

  • Astra Zeneca revises US vaccine trial results after claims of outdated data

    March 25, 2021

    AstraZeneca has confirmed its Covid-19 vaccine as 76 per cent effective after a new US trial, which showed it to be only three per cent lower than previously reported. US health officials criticised interim data published on Monday, which showed the vaccine efficacy rate to be at 79 per cent, but was not the most [...]

  • Going Dutch: Downing Street refuses to rule out sharing Astrazeneca vaccines with EU

    March 23, 2021

    Downing Street has refused to rule out sharing British supplies of the Astrazeneca vaccine made in the Netherlands with the EU to avert an exports ban from the bloc. Asked whether the UK would be willing to offer some of the Dutch-made jabs to Europe, the Prime Minister’s official spokesperson said Boris Johnson has “set [...]

  • US trials show Astrazeneca vaccine safe from blood clot risk and highly effective

    March 22, 2021

    The Astrazeneca Covid-19 vaccine made with Oxford University was 79 per cent effective in a large US trial at preventing symptomatic illness, and was 100 per cent effective against severe or critical disease and hospitalisation, the FTSE-listed drugmaker said this morning. The positive data comes after many countries resuming use of the vaccine after the European [...]

  • France, Spain, Italy and Germany to resume Astrazeneca vaccinations after EU regulator rules jab is ‘safe and effective’

    March 18, 2021

    France, Spain, Italy and Germany are among the European countries that have confirmed they will resume rolling out the Astrazeneca vaccine after the EU medicines regulator said there is “clear scientific” evidence that the jab is both “safe and effective”. Emer Cooke, executive director of the European Medicines Agency (EMA), earlier today said the agency remains [...]

  • Covid-19 vaccine shortage: UK will face ‘significant reduction’ in supply from 29 March

    March 17, 2021

    Covid-19 vaccine shortage: UK will face 'significant reduction' in supply from 29 March

  • WHO says countries should continue to use Astrazeneca Covid-19 vaccine as ‘benefits outweigh risks’

    March 17, 2021

    WHO says countries should continue to use Astrazeneca Covid-19 vaccine as 'benefits outweight risks'

  • EU medicines regulator: ‘No indication’ Astrazeneca vaccine causes blood clots

    March 16, 2021

    The EU’s medicines regulator has insisted there is “no indication” that Astrazeneca’s Covid vaccine causes blood clots among patients, after a swathe of European countries suspended the jab over safety concerns. Emer Cooke, executive director of the European Medicines Agency (EMA), said the agency remains “firmly convinced” that the benefits of the Astrazeneca vaccine outweigh the [...]

  • US may approve Astrazeneca vaccine in April, even as EU states ban jab over blood clot fears

    March 15, 2021

    US may approve Astrazeneca vaccine in April, even as EU states ban jab over blood clot fears

  • Boris Johnson challenges EU after Italy blocks Astrazeneca vaccine shipment

    March 5, 2021

    Boris Johnson has challenged the EU’s decision to approve the blockade of 250,000 doses of the Astrazeneca vaccine from being shipped to Australia. Italy yesterday announced it had blocked the shipment of vaccines made at its Anagni plant near Rome after the British-Swedish drug manufacturer failed to meet its EU contract commitments. The European Commission gave [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Page 27
  • Next

Trending Articles

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • Hargreaves Lansdown orders staff back to office

  • PwC’s Embankment HQ to get major makeover ahead of Canary Wharf move

  • FTSE 100 Live: Stocks drop as US-Iran peace stalls; Oil climbs higher

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook